| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $427.4M | $451.0M | $454.2M |
| YoY Revenue Growth % | -5.2% | -0.7% | — |
| Gross Profit | $109.1M | $124.2M | — |
| Gross Margin % | 25.5% | 27.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $44.2M | $21.7M | -$19.1M |
| Operating Margin % | 10.3% | 4.8% | -4.2% |
| Net Income (GAAP) | -$11.5M | -$12.7M | -$45.0M |
| EBITDA (Normalized) | $56.4M | $35.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $30.6M | $48.7M | $67.8M |
| Capital Expenditures (CapEx) | $15.2M | $17.4M | — |
| Free Cash Flow (FCF) | $15.4M | $31.3M | $67.8M |
| FCF Margin % | 3.6% | 6.9% | 14.9% |
| Return on Invested Capital (ROIC %) | 9.3% | 4.2% | — |
| Cash & Short-Term Equivalents | $4.8M | $33.0M | — |
| Total Debt (Short + Long Term) | $421.2M | $465.8M | — |
| Total Stockholders' Equity | -$41.0M | -$28.4M | — |